SOURCE: Dynavax Technologies

Dynavax Technologies

June 09, 2015 09:00 ET

Dynavax to Present at the William Blair 35th Annual Growth Stock Health Care Conference

BERKELEY, CA--(Marketwired - Jun 9, 2015) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that Michael Ostrach, the Company's Chief Financial Officer, will present at the William Blair 35th Annual Growth Stock Conference on Thursday, June 11, 2015 at 8:00 AM Central Time at the Four Seasons Hotel in Chicago.

A live webcast of the presentation will be available by visiting the "Investors" section of the Dynavax website or may be reached directly at:

http://wsw.com/webcast/blair49/dvax

About Dynavax

Dynavax, a clinical-stage biopharmaceutical company, uses TLR biology to discover and develop novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. Dynavax's lead product candidates are HEPLISAV-B™, a Phase 3 investigational adult hepatitis B vaccine, and SD-101, an investigational cancer immunotherapeutic currently in several Phase 1/2 studies. For more information visit www.dynavax.com.

Contact Information

  • Contact:
    Michael Ostrach
    Chief Financial Officer
    510-665-7257
    Email Contact